IT & Strategy Consulting
for modern R&D organizations
Luat (Luke) Nguyen is an experienced technology strategist specializing in R&D IT, AI/ML integration, and data analytics within the biotech and pharmaceutical industries. With a background in biochemistry/chemistry, computer science, and economics, he has developed a deep understanding of IT infrastructure, product management, and business analysis.
Luke is also an inventor with hands-on experience and proprietary, data-driven scientific expertise in the discovery of highly selective and specific small-molecule drug candidates—over 70% of his proposed compounds were independently validated through experimental studies by scientists at the University of California, San Francisco.
He is a co-author of patents in biosensor arrays (from a spin-off of UC Berkeley and Stanford), calcium ion channel modulators, and receptor tyrosine kinase inhibitors (TrkA program was later acquired by Purdue Pharma), demonstrating an innovative approach to tackling complex scientific and technological challenges. He is passionate about leveraging cutting-edge technologies to drive business value and enhance R&D processes.
Consulting Services
G · I · F · T — a structured engagement model
G — Growth & Fundraising Strategy
Capital strategy, investor readiness, and technical diligence.- Capital strategy for biotech ventures — success-fee & revenue-sharing models aligned to growth.
- Fundraising & investor readiness — support for early-stage and milestone-based funding.
- Technology due diligence — evaluate scientific feasibility & IT infrastructure for investors/startups.
I — Informatics & AI-Driven R&D
Modern scientific platforms that move data reliably from bench to insight.- Scientific informatics strategy — Entity & Assay Registration, Sample Management, ELN, LIMS, lab automation.
- AI & computational chemistry platforms — AI-driven pipelines integrating bioinformatics, ML, and HPC.
- Data governance & security — GxP, HIPAA, GDPR, FDA-aligned integrity and security controls.
F — Future-Ready IT & Digital Transformation
Cloud, hybrid, and on-prem strategies built for regulated R&D reality.- R&D IT strategy & infrastructure — cloud-based, hybrid, and on-prem environments for R&D.
- Enterprise integration & SaaS strategy — vendor selection, implementation, interoperability.
- Agile product management & roadmaps — scalable IT solutions aligned to R&D execution.
T — Technology-Driven Drug Discovery & Cybersecurity
Secure, scalable compute + modern model lifecycle practices.- Computational drug discovery & bioinformatics — AI/ML modeling for small molecules & biologics.
- Cybersecurity & compliance — access controls, vulnerability management, disaster recovery planning.
- Scalable AI/ML infrastructure — automated pipelines, workflow optimization, model lifecycle management.
Featured
Click any image to zoom
The AI Blueprint: Why AlphaFold is the New Foundation of Preclinical Drug Discovery Research
Data lifecycle framing for AI-first preclinical discovery.
The Importance of Basic Research During #AI Era — The Billion-Dollar Shortcut
How we stopped guessing and started engineering better drugs.
Ref: Modernizing Data and Data Science Infrastructure as a Strategic Asset for Cancer Centers
Position data platforms as a strategic asset, not overhead.
Drug Modalities
Illustration and definitions across modern therapeutic modalities.